Particle size reduction of poorly water soluble artemisinin via antisolvent precipitation with a syringe pump

被引:26
作者
Kakran, Mitali [1 ]
Sahoo, Nanda Gopal [1 ]
Li, Lin [1 ]
Judeh, Zaher [2 ]
机构
[1] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore
[2] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore
关键词
Artemisinin; Antisolvent precipitation; Syringe pump; Crystallinity; Particle size; Dissolution; EVAPORATIVE PRECIPITATION; DISSOLUTION; NANOPARTICLES; ARTESUNATE;
D O I
10.1016/j.powtec.2012.12.029
中图分类号
TQ [化学工业];
学科分类号
081705 [工业催化];
摘要
The method called antisolvent precipitation with a syringe pump (APSP) was used for reducing the particle size of a poorly water soluble anti-malarial drug, artemisinin (ART) with the aim of improving its dissolution properties. Various process parameters, such as drug concentration, solvent-antisolvent volume ratio, stirring speed, flow rate and temperature were investigated and optimized to produce the smallest particle size. As part of the design of experiment, a percent dissolution surface response model was regressed and statistically assessed to understand the relationship between the process parameters and percent dissolution. The particle size of the commercial ART was reduced from 26.4 mu m (diameter) and 30.0 mu m (length) to 1.5 mu m (diameter) and 3.8 mu m (length) by the APSP method, which increased the percent dissolution of ART. The DSC and XRD studies revealed that the crystallinity of ART particles prepared was lower than the commercial ART. The XRD study also revealed the fabrication of two polymorphs of ART, i.e. the orthorhombic and triclinic form. Commercial ART and ART particles fabricated by APSP (in the absence of polymers) were orthorhombic whereas ART prepared in the presence of a polymer, polyvinylpyrrolidone or polyethylene glycol, was of triclinic form. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:468 / 476
页数:9
相关论文
共 23 条
[1]
Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells [J].
Augustijns, P ;
DHulst, A ;
VanDaele, J ;
Kinget, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (06) :577-579
[2]
ARTESUNATE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN THE TREATMENT OF MALARIA [J].
BARRADELL, LB ;
FITTON, A .
DRUGS, 1995, 50 (04) :714-741
[3]
Cao G., 2011, NANOSTRUCTURES NANOM, P62
[4]
Chan KL, 1997, PHYTOCHEMISTRY, V46, P1209, DOI 10.1016/S0031-9422(97)00437-8
[5]
Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[6]
Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods [J].
Galindo-Rodriguez, S ;
Allémann, E ;
Fessi, H ;
Doelker, E .
PHARMACEUTICAL RESEARCH, 2004, 21 (08) :1428-1439
[7]
Horn D, 2001, ANGEW CHEM INT EDIT, V40, P4331
[8]
Artemisinin-Polyvinylpyrrolidone Composites Prepared by Evaporative Precipitation of Nanosuspension for Dissolution Enhancement [J].
Kakran, M. ;
Sahoo, N. G. ;
Li, L. ;
Judeh, Z. ;
Panda, P. .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2011, 22 (1-3) :363-378
[9]
Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension [J].
Kakran, M. ;
Sahoo, N. G. ;
Li, L. ;
Judeh, Z. ;
Wang, Y. ;
Chong, K. ;
Loh, L. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 383 (1-2) :285-292
[10]
Fabrication of quercetin nanoparticles by anti-solvent precipitation method for enhanced dissolution [J].
Kakran, Mitali ;
Sahoo, Nanda Gopal ;
Li, Lin ;
Judeh, Zaher .
POWDER TECHNOLOGY, 2012, 223 :59-64